Table 1.
Conjugate | Total AleA (% w/w) | Total AmB (% w/w) | Free AmB (% total drug) | ||
---|---|---|---|---|---|
1 | Poly(HPMA)–GFLG–ONp | — | — | ||
3 | CIR1790 | Poly(HPMA)–GFLG–AleA | 7.9 | ||
4 | CIR1791 | Poly(HPMA)–GFLG–AmB–AleA | 5.5 | 8.2 | <1.0 |
5 | CIR1792 | Poly(HPMA)–GFLG–AmB–AleA | 3.9 | 13.4 | <1.0 |
6 | CIR1793 | Poly(HPMA)–GFLG–AmB–AleA | 1.8 | 19.6 | <1.0 |
7 | CIR1668 | Poly(HPMA)–GFLG–AmB | — | 9.6 | <0.1 |
8 | CIR1783 | Poly(HPMA)–GFLG–AmB | — | 16.9 | <0.1 |
9 | CIR1465 | Poly(HPMA)–GFLG–COOH | — | — | — |
10 | CIR1466 | Poly(HPMA)–GFLG–AP | — | — | — |
CIR1465, CIR1466 and CIR1668 have been reported previously.11